MIR · Mirion Technologies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $257.60M | - | $223.10M | $222.90M | $202.00M | - | $206.80M | $207.10M | $192.60M | - |
| Cost of Revenue | $138.50M | - | $118.60M | $120.40M | $105.90M | - | $113.90M | $109.20M | $105.50M | - |
| Gross Profit | $119.10M | - | $104.50M | $102.50M | $96.10M | - | $92.90M | $97.40M | $87.10M | - |
| R&D | $9.60M | - | $10.10M | $10.00M | $8.70M | - | $10.20M | $8.80M | $7.90M | - |
| SG&A | $105.80M | - | $87.00M | $82.60M | $78.70M | - | $84.30M | $87.50M | $84.10M | - |
| Total Operating Expenses | $115.40M | - | $97.10M | $92.60M | $87.40M | - | $94.50M | $95.10M | $92.00M | - |
| D&A | $40.80M | - | $34.90M | $38.50M | $38.70M | - | - | - | - | - |
| Operating Income | $3.70M | - | $7.40M | $9.90M | $8.70M | - | ($1.60M) | $2.30M | ($4.90M) | - |
| Interest Expense | - | - | - | - | - | - | $14.10M | $14.60M | $15.50M | - |
| Income Tax | ($1.80M) | - | ($1.90M) | ($700.0K) | $200.0K | - | $1.00M | $700.0K | $1.20M | - |
| Net Income | ($3.40M) | - | $2.90M | $8.30M | $300.0K | - | ($13.60M) | ($11.70M) | ($25.80M) | - |
| EPS - Basic | ($0.01) | - | $0.01 | $0.04 | $0.00 | - | ($0.07) | ($0.06) | ($0.13) | - |
| EPS - Diluted | ($0.01) | - | $0.01 | $0.03 | $0.00 | - | ($0.07) | ($0.06) | ($0.13) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $397.90M | $412.30M | $933.20M | $262.60M | $185.80M | $175.20M | $133.30M | $122.20M | $120.20M | $128.80M |
| Accounts Receivable | $181.50M | $181.60M | $150.00M | $142.20M | $147.80M | $177.70M | $148.60M | $143.10M | $146.10M | $172.30M |
| Inventory | $157.90M | $152.60M | $146.00M | $145.10M | $143.50M | $133.20M | $154.00M | $148.30M | $146.80M | $144.10M |
| Accounts Payable | $66.10M | $57.40M | $49.40M | $45.60M | $51.70M | $56.50M | $53.10M | $52.20M | $53.10M | $58.70M |
| Current Assets | $890.90M | $893.70M | $1.39B | $693.20M | $590.20M | $594.70M | $546.50M | $515.40M | $514.60M | $538.60M |
| Total Assets | $3.54B | $3.59B | $3.50B | $2.74B | $2.63B | $2.64B | $2.65B | $2.63B | $2.65B | $2.72B |
| Current Liabilities | $279.20M | $316.10M | $287.00M | $272.40M | $265.00M | $263.40M | $252.60M | $236.20M | $234.60M | $265.70M |
| Long-term Debt | $443.50M | $443.10M | $443.20M | $444.50M | $685.90M | $685.20M | $684.50M | $684.00M | $685.40M | $684.70M |
| Total Liabilities | $1.65B | $1.67B | $1.60B | $1.22B | $1.07B | $1.08B | $1.08B | $1.06B | $1.13B | $1.17B |
| Stockholders' Equity | $1.84B | $1.87B | $1.84B | $1.46B | $1.50B | $1.51B | $1.52B | $1.51B | $1.46B | $1.48B |
| Retained Earnings | ($516.10M) | ($512.70M) | ($530.00M) | ($532.90M) | ($541.20M) | ($541.50M) | ($556.50M) | ($542.90M) | ($531.20M) | ($505.40M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $18.90M | - | - | - | $35.60M | - | - | - | $6.00M | - |
| Investing Cash Flow | ($9.20M) | - | - | - | ($7.60M) | - | - | - | ($12.90M) | - |
| Financing Cash Flow | ($19.90M) | - | - | - | ($21.20M) | - | - | - | $200.0K | - |
| CapEx | $9.50M | - | - | - | $8.50M | - | - | - | $12.80M | - |
| Free Cash Flow | $9.40M | - | - | - | $27.10M | - | - | - | ($6.80M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 46.2% | - | 46.8% | 46.0% | 47.6% | - | 44.9% | 47.0% | 45.2% | - |
| Operating margin | 1.4% | - | 3.3% | 4.4% | 4.3% | - | -0.8% | 1.1% | -2.5% | - |
| EBITDA margin | 17.3% | - | 19.0% | 21.7% | 23.5% | - | - | - | - | - |
| Net margin | -1.3% | - | 1.3% | 3.7% | 0.1% | - | -6.6% | -5.6% | -13.4% | - |
| Free cash flow margin | 3.6% | - | - | - | 13.4% | - | - | - | -3.5% | - |
| FCF / Net income | -2.76 | - | - | - | 90.33 | - | - | - | 0.26 | - |
| R&D / Revenue | 3.7% | - | 4.5% | 4.5% | 4.3% | - | 4.9% | 4.2% | 4.1% | - |
| SG&A / Revenue | 41.1% | - | 39.0% | 37.1% | 39.0% | - | 40.8% | 42.3% | 43.7% | - |
| Effective tax rate | - | - | -190.0% | -9.2% | 40.0% | - | - | - | - | - |
| Return on assets | -0.1% | - | 0.1% | 0.3% | 0.0% | - | -0.5% | -0.4% | -1.0% | - |
| Return on equity | -0.2% | - | 0.2% | 0.6% | 0.0% | - | -0.9% | -0.8% | -1.8% | - |
| Return on invested capital | 0.1% | - | 0.3% | 0.5% | 0.2% | - | -0.1% | 0.1% | -0.2% | - |
| Liquidity | ||||||||||
| Current ratio | 3.19 | 2.83 | 4.83 | 2.54 | 2.23 | 2.26 | 2.16 | 2.18 | 2.19 | 2.03 |
| Quick ratio | 2.63 | 2.34 | 4.32 | 2.01 | 1.69 | 1.75 | 1.55 | 1.55 | 1.57 | 1.48 |
| Cash ratio | 1.43 | 1.30 | 3.25 | 0.96 | 0.70 | 0.67 | 0.53 | 0.52 | 0.51 | 0.48 |
| Leverage | ||||||||||
| Debt / Equity | 0.24 | 0.24 | 0.24 | 0.30 | 0.46 | 0.46 | 0.45 | 0.45 | 0.47 | 0.46 |
| Debt / Assets | 0.13 | 0.12 | 0.13 | 0.16 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.25 |
| Debt / EBITDA | 9.97 | - | 10.48 | 9.18 | 14.47 | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | -0.1x | 0.2x | -0.3x | - |
| Equity multiplier | 1.92 | 1.92 | 1.90 | 1.87 | 1.75 | 1.75 | 1.75 | 1.74 | 1.82 | 1.83 |
| Liabilities / Assets | 0.47 | 0.47 | 0.46 | 0.45 | 0.41 | 0.41 | 0.41 | 0.40 | 0.43 | 0.43 |
| Efficiency | ||||||||||
| Asset turnover | 0.07 | - | 0.06 | 0.08 | 0.08 | - | 0.08 | 0.08 | 0.07 | - |
| Inventory turnover | 0.88 | - | 0.81 | 0.83 | 0.74 | - | 0.74 | 0.74 | 0.72 | - |
| Days sales outstanding | 257d | - | 245d | 233d | 267d | - | 262d | 252d | 277d | - |
| Days inventory outstanding | 416d | - | 449d | 440d | 495d | - | 494d | 496d | 508d | - |
| Days payable outstanding | 174d | - | 152d | 138d | 178d | - | 170d | 174d | 184d | - |
| Cash conversion cycle | 499d | - | 543d | 534d | 583d | - | 586d | 573d | 601d | - |
| Valuation | ||||||||||
| P / E | - | - | 2326.0x | 717.7x | - | - | - | - | - | - |
| P / B | 2.5x | - | 3.2x | 3.6x | 2.2x | - | 1.5x | 1.4x | 1.6x | - |
| P / S | 17.7x | - | 26.7x | 23.5x | 16.3x | - | 11.1x | 10.5x | 11.8x | - |
| EV / EBITDA | 103.2x | - | 129.0x | 111.9x | 80.0x | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 27.5% | - | 7.9% | 7.6% | 4.9% | - | 8.2% | 5.0% | 5.8% | - |
| Revenue CAGR (3y) | 12.3% | - | 15.6% | 8.2% | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 23.9% | - | 12.5% | 5.2% | 10.3% | - | 15.0% | 10.7% | 10.1% | - |
| Operating income growth (YoY) | -57.5% | - | - | 330.4% | - | - | 85.6% | - | 64.0% | - |
| Net income growth (YoY) | - | - | - | - | - | - | -12.4% | 57.8% | 38.4% | - |
| EPS growth (YoY) | - | - | - | - | - | - | -16.7% | 57.1% | 40.9% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -65.3% | - | - | - | - | - | - | - | 33.3% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 22.2% | 24.0% | 21.2% | -3.0% | 3.2% | 1.4% | 2.7% | 0.6% | -4.2% | 6.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$925.40M totalNuclear Safety Segment$614.60M · 66.4%
Medical Segment$310.80M · 33.6%
Product / service
$1.85B totalProduct$690.60M · 37.3%
Nuclear$374.60M · 20.2%
Cancer Care$237.00M · 12.8%
Service$234.80M · 12.7%
Labs And Research$122.20M · 6.6%
Other Research$117.80M · 6.4%
Other Care$73.80M · 4.0%
Geographic
$1.05B totalUS$525.90M · 50.3%
North America$279.30M · 26.7%
FR$193.70M · 18.5%
Europe$31.50M · 3.0%
Asia Pacific$15.60M · 1.5%
Peer comparison
Same SIC group: Measuring & Controlling Devices, NEC
Comparing Mirion Technologies against the 5 most active filers in the same SIC group.